When a Korean sunscreen brand decides to sell properly in the United States, it faces a choice most shoppers never see. The filters that make Korean sunscreens famous for feeling like nothing, the Uvinul and Tinosorb families, have never been approved by the FDA, so a brand can either ship the original formula through grey-market channels and hope, or rebuild the product around the short list of filters the American monograph allows. Goodal took the second route with this one, registered it on DailyMed under Clio Cosmetics as an OTC sunscreen drug, and in the process made a decision that says more about the product than any filter choice: it dropped the fragrance entirely. The Korean-market sun serum in the same Green Tangerine line runs on alcohol and five essential oils. This U.S. formula lists none of them. For a brand whose signature is a bright citrus smell, that is a real concession to how the American sensitive-skin market shops, and it is the reason this sunscreen deserves a different audience from its sibling.
The filter system is the classic U.S. set: homosalate at 9.5 percent, octocrylene at 9, octisalate at 4.75 and avobenzone at 2.85. None of those numbers are at the monograph maximum, which is the first sign of thoughtful work. Avobenzone is the only UVA filter available to a monograph product and it is notoriously unstable in sunlight; the formula addresses that twice, with octocrylene doing its usual stabilising job and, more interestingly, with ethylhexyl methoxycrylene sitting fifth on the inactive list. That is a dedicated photostabiliser whose only purpose is to keep avobenzone intact, and its presence is what separates a well-built avobenzone sunscreen from a lazy one. Butyloctyl salicylate two lines later is an SPF booster, which explains how the filters can sit at moderate levels and still test to SPF 50 under the FDA method. The texture benefits directly: a milky lotion-cream that spreads thin, absorbs in about a minute and settles to a soft satin with a hint of dew, no cast on any skin tone, and no eye sting, which is a small miracle for a chemical sunscreen.
Then there is the brightening cast, and it is better assembled than most sunscreens manage. Niacinamide is eighth on the inactive list, above the preservative and every emulsifier, which is a placement that implies a few percent rather than a trace. Arbutin follows at twelfth. And further down sits acetyl glucosamine, an amino sugar that interferes with the enzyme machinery of pigment production and which has been trialled specifically in combination with niacinamide, where the pair outperformed niacinamide alone on facial hyperpigmentation over eight weeks. That is a formulation choice made by someone who read the literature, not the marketing brief. The honest caveat is dose: acetyl glucosamine here is well below the 2 percent used in that trial, and no concentration is declared for any of the three. What the sunscreen offers is a daily, low-level assist that pulls in the same direction as the filters, plus, and this is the part that matters, a filter system that stops existing spots getting darker. For anyone managing hyperpigmentation, consistent SPF is the treatment that matters most, and a sunscreen that is pleasant enough to wear every single day is worth more than any additive.
The vitamin C, as usual with this line, is the smallest part of the story. Ascorbic acid and ascorbyl glucoside both sit near the end of the list, behind allantoin, in antioxidant-garnish territory. The green tangerine extract is second on the inactive list, which is unusually high and means it is contributing real volume, though what an unripe tangerine extract does at that level beyond flavonoid antioxidant support is not something the brand has shown. It is fine to enjoy the branding as long as nobody buys this instead of a vitamin C serum.
Where the formula can disappoint is in expectations set by the Korean version. Anyone who loved the flash-dry, powder-matte feel of the sun serum will find this one softer and slightly dewier, and on very oily skin that dew can read as shine by mid-afternoon. It also costs more, around twenty-three dollars against twenty for the Korean tube, for a filter system that is, in pure UVA terms, less elegant. The price premium is buying FDA registration, a fragrance-free formula and the DailyMed transparency that lets anyone read exactly what is in it, which for a lot of people is exactly the right thing to pay for, but it is worth being clear-eyed that the extra dollars are not buying better filters.
Sixteen months on the U.S. market and around eleven hundred Amazon ratings at a 4.4 average is a decent early record for a 2025 launch, with the praise clustering exactly where the formula deserves it: no scent, no cast, no sting, comfortable under makeup. The complaints are mostly about the dewy finish and the small tube, which at a proper quarter-teaspoon dose lasts about six weeks. Neither is a flaw so much as a fact of the category.
So who is this for? Anyone in the United States who wants a brightening-adjacent chemical sunscreen without fragrance or alcohol, which includes a lot of sensitive, rosacea-adjacent and retinoid-using skin that the Korean version would have stung. Normal, combination and moderately oily skin will wear it happily year-round; dry skin will like the hydration; very oily skin may want the matte sibling instead. It is a well-built, honestly registered, genuinely comfortable everyday sunscreen with a smarter brightening lineup than it needed to include. That it exists at all, from a brand whose identity is a citrus scent, is the most persuasive thing about it.
